Paper37065752
Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.
Chertok Shacham E and 6 others. Front Endocrinol (Lausanne), 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level. Papers, record 37065752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37065752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperparathyroidism, Primary | Major topic |
| Hypercalcemia | Major topic |
| Humans | |
| Calcium | |
| Fibroblast Growth Factor-23 | |
| Vitamin D | |
| Calcifediol |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20685823 | PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. | Am J Physiol Renal Physiol | 2010 | https://conductscience.org/library/papers/20685823 | PubMed |
| 2 | 32803112 | Normocalcemic Hyperparathyroidism: A Heterogeneous Disorder Often Misdiagnosed? | JBMR Plus | 2020 | https://conductscience.org/library/papers/32803112 | PubMed |
| 3 | 15248822 | Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism. | Eur J Endocrinol | 2004 | https://conductscience.org/library/papers/15248822 | PubMed |
| 4 | 17554146 | Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. | J Am Soc Nephrol | 2007 | https://conductscience.org/library/papers/17554146 | PubMed |
| 5 | 23677793 | Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic Fractures in Men (MrOS) study. | J Bone Miner Res | 2013 | https://conductscience.org/library/papers/23677793 | PubMed |
| 6 | 32598019 | FGF23 and primary hyperparathyroidism: is there a link? | Endokrynol Pol | 2020 | https://conductscience.org/library/papers/32598019 | PubMed |
| 7 | 30665550 | Management of normocalcemic primary hyperparathyroidism. | Best Pract Res Clin Endocrinol Metab | 2018 | https://conductscience.org/library/papers/30665550 | PubMed |
| 8 | 34860179 | Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism. | Endocr Connect | 2022 | https://conductscience.org/library/papers/34860179 | PubMed |
| 9 | 26332755 | Clinical Expression of Calcium Sensing Receptor Polymorphism (A986S) in Normocalcemic and Asymptomatic Hyperparathyroidism. | Horm Metab Res | 2016 | https://conductscience.org/library/papers/26332755 | PubMed |
| 10 | 34300255 | Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism. | J Clin Med | 2021 | https://conductscience.org/library/papers/34300255 | PubMed |
| 11 | 17565275 | Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. | Curr Opin Nephrol Hypertens | 2007 | https://conductscience.org/library/papers/17565275 | PubMed |
| 12 | 12711740 | Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12711740 | PubMed |
| 13 | 32606893 | Evaluation of Serum Level of FGF23 and 1,25(OH)2D3 in Primary Hyperparathyroidism Patients Before and After Parathyroidectomy. | Int J Gen Med | 2020 | https://conductscience.org/library/papers/32606893 | PubMed |
| 14 | 33015068 | Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/33015068 | PubMed |
| 15 | 27498418 | Fgf23 and parathyroid hormone signaling interact in kidney and bone. | Mol Cell Endocrinol | 2016 | https://conductscience.org/library/papers/27498418 | PubMed |
| 16 | 21984611 | Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism? | Eur J Endocrinol | 2012 | https://conductscience.org/library/papers/21984611 | PubMed |
| 17 | 35380024 | Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism. | J Korean Med Sci | 2022 | https://conductscience.org/library/papers/35380024 | PubMed |
| 18 | 31557077 | LOW FREE (BUT NOT TOTAL) 25-HYDROXYVITAMIN D LEVELS IN SUBJECTS WITH NORMOCALCEMIC HYPERPARATHYROIDISM. | Endocr Pract | 2020 | https://conductscience.org/library/papers/31557077 | PubMed |
| 19 | 32072184 | Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History. | J Clin Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32072184 | PubMed |
| 20 | 23700148 | Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia. | Calcif Tissue Int | 2013 | https://conductscience.org/library/papers/23700148 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40949872 | Comparative analysis of blood whole transcriptome profiles in Yili horses pre- and post-5000-meter racing. | Front Genet | 2025 | https://conductscience.org/library/papers/40949872 | PubMed |
| 39518465 | Osteoporosis and Normocalcemic Primary Hyperparathyroidism (Conservatively or Surgically Managed). | J Clin Med | 2024 | https://conductscience.org/library/papers/39518465 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CASR | 846 | PubTator's text mining | https://conductscience.org/library/genes/846 | NCBI Gene |
| CYP27A1 | 1593 | PubTator's text mining | https://conductscience.org/library/genes/1593 | NCBI Gene |
| FGF23 | 8074 | PubTator's text mining | https://conductscience.org/library/genes/8074 | NCBI Gene |
| FGFR1 | 2260 | PubTator's text mining | https://conductscience.org/library/genes/2260 | NCBI Gene |
| KL | 9365 | PubTator's text mining | https://conductscience.org/library/genes/9365 | NCBI Gene |
| PTH | 5741 | PubTator's text mining | https://conductscience.org/library/genes/5741 | NCBI Gene |
| TRPV5 | 56302 | PubTator's text mining | https://conductscience.org/library/genes/56302 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37065752
GET https://conductscience.org/api/papers/v1/37065752/references?page=2